Labthera-001
WebOct 16, 2024 · The primary goal of this phase I open label study is to determine the safety and tolerability of pNGVL4aCRTE6E7L2 DNA vaccine, as administered by intramuscular (IM) injection with TriGrid™ electroporation to both HIV- or HIV+ adult female subjects (≥ 19 years), with biopsy confirmed cervical intraepithelial (CIN) II or III that is human … WebA vérképző őssejt-transzplantációt sokan alkalmazzák a gyermekkori korosztályban okok, mint például hematológiai rosszindulatú daganatok, ... Klinikai vizsgálatok nyilvántartása. ICH GCP.
Labthera-001
Did you know?
WebApr 8, 2024 · LABthera-001: Infectious diseases: Bacterial Vaginosis: Preclinical: Single Strain: LABthera-002: Oncology: Cancer, Cachexia: Preclinical: Single Strain: LABthera … WebMay 1, 2013 · Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study - ScienceDirect European Journal of Obstetrics & Gynecology and Reproductive Biology Volume 168, Issue 1, May 2013, Pages 75-79
WebAvoin etiketti, turvallisuustutkimus lisämunuaisen vaimennuksen mahdollisuuden arvioimiseksi Hoito DSXS: llä (Taro Pharmaceuticals U.S.A., Inc.) ... Kliinisten ... WebAug 1, 2010 · One hundred twenty healthy Chinese women with a history of recurrent BV were assigned randomly to daily vaginal prophylaxis with 1 capsule (Probaclac Vaginal; Nicar Laboratories, Inc, Blainville,...
WebThe main subject is to investigate the safety and tolerability of the LABTHERA-001 capsule and to explore the acceptability of the capsule. Conditions: Bacterial Vaginosis, Vaginal … WebMar 1, 2012 · In a randomized, double-blind, placebo-controlled trial (RDBPCT), 100 women (mean age 34 years) with BV were treated with 2% clindamycin cream for 7 days and then …
WebOct 27, 2000 · This study will explore new screening methods for early detection of breast and ovarian cancer in women at high risk for these diseases, because they have an altered breast cancer 1 (BRCA1) or breast cancer 2 (BRCA2) gene.
WebApr 13, 2016 · To compare the efficacy and safety of two doses of clotrimazole vaginal tablet 500 mg with two doses of oral fluconazole 150 mg in treating severe vulvovaginal candidiasis (SVVC), 240 consecutive patients with SVVC were studied at the Department of Obstetrics and Gynaecology of Peking University Shenzhen Hospital between June 2014, … orange phase mx teamWebMar 31, 2024 · Gardnerella vaginalis contributes significantly to bacterial vaginosis, which causes an ecological imbalance in vaginal microbiota and presents with the depletion of Lactobacillus sp. Lactobacillus supplementation was reported to be an approach to treat bacterial vaginosis. We investigated the applicability of three Lactobacillus sp. strains … iphone vacation messageWebMar 6, 2024 · This study's goal was to determine how denosumab 60 mg, combined with total contact casting and restricted weightbearing status, would affect the treatment of a... orange phialWebmicrobiota. The possible mechanisms of the probiotics acting in the vagina include modulation of host immunity, alteration of the microenvironment to be less receptive to pathogens (i.e. the pro- orange phase mx reviewWebFeb 7, 2013 · Long-term use of Lactobacillus is safe that it becomes an alternative for antibiotics, especially in recurrent vaginal infections. 11 The mechanism of actions of … orange phikwe marathon 2022WebFeb 18, 2024 · LABthera-001 in Bacterial Vaginosis Drug Details: LABthera-001 is under development for the treatment of bacterial vaginosis. The drug candidate is a consortia of … orange phikwe marathonWebApr 19, 2024 · A Phase 1/1b Study of MPT-0118 as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Refractory Solid Tumors This is a Phase 1/1b open-label, dose-escalation, and cohort expansion study with BID (tablet) oral dose of MPT-0118 in subjects with advanced or metastatic refractory solid tumors. orange pheasant hat